Condition
Heterozygous Familial Hypercholesterolemia clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Heterozygous Familial Hypercholesterolemia clinical trials that are recruiting, at sites in 7 countries (most in Australia (1), Canada (1), Israel (1)). By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 7Countries
All recruiting trials (2)
-
Evaluating HST101 for lowering cholesterol in Chinese patients
This study is testing if a new drug called HST101 can lower cholesterol levels in Chinese patients who have high cholesterol and are at risk for heart disease.
-
Evaluating VERVE-102 for lowering cholesterol in specific heart disease patients
This study is testing a new gene-editing treatment called VERVE-102 to see if it can lower cholesterol levels in people with certain heart conditions.
Related topics
Quick answers
How many Heterozygous Familial Hypercholesterolemia clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Australia (1 trial), Canada (1 trial), Israel (1 trial), New Zealand (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.